EANS-Adhoc: CURANUM AG / Financial Figures 2009

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

31.03.2010

Ad hoc announcement

CURANUM AG publishes 2009 results

Occupancy stable in 2009, revenue and EBITDA budgets achieved

CURANUM AG, Munich, announces its results for the 2009
financial year at today's results press conference and analyst
meeting in Frankfurt. The capacity utilization of care beds and
managed apartments was stable in 2009, albeit at a somewhat lower
average level than in 2008.

Revenue rose by 1.0% from EUR 257.1 million in 2008 to EUR 259.5
million in 2009, an increase of EUR 2.4 million. We thereby
exceeded our revenue budget (EUR 257.0 million to EUR 259.0
million). The increase was due to revenue from our new Scheffelhof
senior residence in Bad Dürrheim, the senior citizen residence
and care facility in Braunschweig, as well as additional
revenues from our outpatient service in Coburg, and from care
services for occupants suffering dementia.

Rental expenses rose by EUR 0.9 million or 1.65% to EUR 55.5 million
(previous year: EUR 54.6 million). This was mainly due to the rental
indexations of the properties we rent. Staff costs increased by
EUR 2.7 million or 2.1%, from EUR 127.8 million in 2008 to
EUR 130.5 million in 2009.

As a consequence, earnings before interest, tax, depreciation,
amortization and rents (EBITDAR) amounted to EUR 83.1 million in
2009 (previous year: EUR 83.9 million), reflecting a decline of
EUR 0.8 million or 0.95% year-on-year. The EBITDAR margin stood
at 32.0% (previous year: 32.6%), which represents a peak outcome
on a European peer group comparison.

EBITDA earnings declined from EUR 29.3 million in 2008 to EUR 27.6
million in 2009, which corresponds to an EBITDA margin of 10.64% in
this reporting period (previous year: 11.4%).

Compared with the previous year, depreciation and amortization
rose only slightly from EUR 9.5 million in 2008 to EUR 9.8 million
in 2009, representing an increase of EUR 0.3 million or 3.16%. As
a consequence, earnings before interest and tax (EBIT) amounted to
EUR 17.8 million (previous year: EUR 19.7 million), reflecting an
EBIT margin of 6.86% in 2009 (previous year: 7.66%).

The tax rate increased in 2009. Consequently, income tax and deferred
tax were around EUR 0.7 million higher than budgeted. At EUR 5.8
million (previous year: EUR 7.0 million) we failed to achieve our
budgeted post-tax earnings of EUR 6.5 million - EUR 8.5 million.
Earnings per share amounted to EUR 0.18 in the 2009 reporting
period (previous year: EUR 0.22).

Cash flow from operating activities rose slightly from EUR 19.8
million to EUR 19.9 million as of the end of 2009, and the cash
outflow from investing activities dropped from EUR 18.7 million to
EUR 5.2 million in 2009. Cash flow from financing activities was
again characterized by the redemption of financial liabilities
in an amount of EUR 5.6 million (previous year: EUR 4.9 million),
outgoing payments for finance leasing of EUR 7.8 million
(previous year: EUR 7.6 million), as well as the dividend payment at
the previous year's level at EUR 3.2 million.

The full results for the 2009 financial year are available on our
website at www.curanum.de in the Investor Relations area.

Munich, March 31, 2010

The Management Board

|Key figures IFRS as of December 31, | | |
|2009 | | |
| | | | |
| | | | |
|mil. EUR |2009 |2008 1) |YOY in % |
| | | | |
|Sales |259.5 |257.1 |0.93 |
|Staff costs |130.5 |127.8 |2.11 |
|EBITDAR |83.1 |83.9 |-0.95 |
|Rental costs |55.5 |54.6 |1.65 |
|EBITDA |27.6 |29.3 |-5.80 |
|in % of Sales |10.6% |11.4% | |
|Depreciation |9.8 |9.5 |3.16 |
|EBIT |17.8 |19.7 |-9.64 |
|in % of Sales |6.9% |7.7% | |
|Financial results |-8.9 |-9.5 |-6.32 |
|EBT |8.9 |10.2 |-12.75 |
|Net profit |5.8 |7.0 |-17.14 |
|EPS (EUR) *) |0.18 |0.22 |-18.18 |
| | | | |
|Cashflow |19.9 |19.8 |0.51 |
|CPS (EUR) *) |0.62 |0.61 |1.64 |
| | | | |
|Cash and cash equivalents |8.9 |10.0 |-11.00 |
|Equity capital |66.1 |64.1 |3.12 |
|in % of balance sheet total |28.0% |27.0% | |
|Balance sheet total |236.4 |237.7 |-0.55 |
| | | | |
|Employees |6,055 |5,953 |1.71 |
|Facilities |69 |68 |1.47 |
|Care places |7,805 |7,708 |1.26 |
|Assisted living apartements |1,681 |1,638 |2.63 |
| | | | |
|*) Number of unterlying outstanding | | |
|shares in 2009: 32,267,835 shares | | |
|*) Number of underlying outstanding | | |
|shares in 2008: 32,611,091 shares | | |
|1) restated in 2009 | | |

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: CURANUM AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Marion Mühlschlegel

Tel. +49 (0)89 242065-68

Email marion.muehlschlegel@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing